|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for DGKD |
Basic gene info. | Gene symbol | DGKD |
Gene name | diacylglycerol kinase, delta 130kDa | |
Synonyms | DGKdelta|dgkd-2 | |
Cytomap | UCSC genome browser: 2q37.1 | |
Genomic location | chr2 :234263152-234380743 | |
Type of gene | protein-coding | |
RefGenes | NM_003648.2, NM_152879.2, | |
Ensembl id | ENSG00000077044 | |
Description | DAG kinase deltaDGK-deltadiacylglycerol kinase deltadiglyceride kinase delta | |
Modification date | 20141207 | |
dbXrefs | MIM : 601826 | |
HGNC : HGNC | ||
Ensembl : ENSG00000077044 | ||
HPRD : 03492 | ||
Vega : OTTHUMG00000133290 | ||
Protein | UniProt: Q16760 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DGKD | |
BioGPS: 8527 | ||
Gene Expression Atlas: ENSG00000077044 | ||
The Human Protein Atlas: ENSG00000077044 | ||
Pathway | NCI Pathway Interaction Database: DGKD | |
KEGG: DGKD | ||
REACTOME: DGKD | ||
ConsensusPathDB | ||
Pathway Commons: DGKD | ||
Metabolism | MetaCyc: DGKD | |
HUMANCyc: DGKD | ||
Regulation | Ensembl's Regulation: ENSG00000077044 | |
miRBase: chr2 :234,263,152-234,380,743 | ||
TargetScan: NM_003648 | ||
cisRED: ENSG00000077044 | ||
Context | iHOP: DGKD | |
cancer metabolism search in PubMed: DGKD | ||
UCL Cancer Institute: DGKD | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of DGKD in cancer cell metabolism | 1. Sakai H, Sakane F (2012) Recent progress on type II diacylglycerol kinases: the physiological functions of diacylglycerol kinase delta, eta and kappa and their involvement in disease. J Biochem 152: 397-406. doi: 10.1093/jb/mvs104. go to article 2. Wang H, Xiao L, Kazanietz MG (2011) p23/Tmp21 associates with protein kinase Cdelta (PKCdelta) and modulates its apoptotic function. J Biol Chem 286: 15821-15831. doi: 10.1074/jbc.M111.227991. pmid: 3091192. go to article 3. Crotty TM, Nakano T, Stafforini DM, Topham MK (2013) Diacylglycerol kinase delta modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2). J Biol Chem 288: 1439-1447. doi: 10.1074/jbc.M112.407379. pmid: 3548457. go to article |
Top |
Phenotypic Information for DGKD(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: DGKD |
Familial Cancer Database: DGKD |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_GLYCEROLIPID_METABOLISM KEGG_GLYCEROPHOSPHOLIPID_METABOLISM |
Others | |
OMIM | 601826; gene. |
Orphanet | |
Disease | KEGG Disease: DGKD |
MedGen: DGKD (Human Medical Genetics with Condition) | |
ClinVar: DGKD | |
Phenotype | MGI: DGKD (International Mouse Phenotyping Consortium) |
PhenomicDB: DGKD |
Mutations for DGKD |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
breast | DGKD | chr2 | 234361403 | 234361403 | LOC285692 | chr5 | 9834538 | 9834538 |
ovary | DGKD | chr2 | 234374735 | 234374755 | DGKD | chr2 | 234377078 | 234377098 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows DGKD related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BE245442 | BRD9 | 1 | 98 | 5 | 863856 | 863953 | DGKD | 94 | 295 | 2 | 234373442 | 234373643 | |
BM151326 | BRD9 | 17 | 114 | 5 | 863856 | 863953 | DGKD | 110 | 309 | 2 | 234373444 | 234373643 | |
BM150804 | BRD9 | 17 | 114 | 5 | 863856 | 863953 | DGKD | 110 | 361 | 2 | 234373392 | 234373643 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   |   |   |   |   |   |   |   | 2 |   |   |   |   |   |   |   |   | |||
GAIN (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   | 2 |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=89) | (# total SNVs=30) |
(# total SNVs=2) | (# total SNVs=2) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr2:234368926-234368926 | p.M972I | 3 |
chr2:234359623-234359623 | p.S698S | 3 |
chr2:234343074-234343074 | p.E133* | 2 |
chr2:234296985-234296985 | p.R80Q | 2 |
chr2:234296986-234296986 | p.R80R | 2 |
chr2:234345025-234345025 | p.D253N | 2 |
chr2:234371341-234371341 | p.R1049H | 2 |
chr2:234377116-234377116 | p.S1158C | 2 |
chr2:234355371-234355371 | p.A450T | 2 |
chr2:234346077-234346077 | p.K292E | 2 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 3 | 5 | 1 | 25 | 6 |   | 1 |   | 1 | 1 |   | 8 | 7 | 4 |   |   | 13 | 7 |   | 14 |
# mutation | 3 | 5 | 1 | 25 | 6 |   | 1 |   | 1 | 1 |   | 8 | 8 | 4 |   |   | 15 | 8 |   | 21 |
nonsynonymous SNV | 3 | 2 | 1 | 20 | 6 |   | 1 |   |   | 1 |   | 6 | 5 | 3 |   |   | 9 | 4 |   | 17 |
synonymous SNV |   | 3 |   | 5 |   |   |   |   | 1 |   |   | 2 | 3 | 1 |   |   | 6 | 4 |   | 4 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr2:234359623 | p.S654S,DGKD | 3 |
chr2:234368407 | p.R36Q,DGKD | 2 |
chr2:234368410 | p.R36R,DGKD | 2 |
chr2:234296985 | p.D209N,DGKD | 2 |
chr2:234371341 | p.R1005H,DGKD | 2 |
chr2:234296986 | p.R856H,DGKD | 2 |
chr2:234345025 | p.T857R,DGKD | 2 |
chr2:234296918 | p.A1052S,DGKD | 1 |
chr2:234355371 | p.T144T,DGKD | 1 |
chr2:234363425 | p.R329W,DGKD | 1 |
Other DBs for Point Mutations |
Copy Number for DGKD in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for DGKD |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ACIN1,ADCY6,ATG16L1,CASZ1,CRIPAK,D2HGDH,DGKD, EHMT1,FARP2,ING5,KIAA0556,LOC338799,MLPH,MYO15B, PLXNB1,PSD4,RBM5,SEC16A,SRSF5,SGSM2,USP40 | VWA7,CEP85,DGKD,DUSP28,GPR157,HIF1AN,LMO7, MAST2,NEU3,P2RY2,PPM1J,PPP2R3B,PTPN3,SBK1, SEMA4D,SIX4,SLC20A2,TADA2B,USP19,USP28,ZNF76 | ||||
AHSA2,ATAT1,MIR600HG,CAPN10,CBFA2T2,CCDC93,CROCCP2, DGKD,EDC4,FAM168B,ING5,JRK,LOC100129637,LOC91316, LPIN3,MLLT6,NSUN5P1,RBM33,SS18L1,TET3,TUBGCP6 | ADCY6,ARHGAP27,ARID3B,CDC42BPG,CLN8,CNNM2,CTDP1, DGKD,DGKQ,DNM2,ELF4,FAM83G,FGFR3,CEP170B, KLF13,LMTK2,LOC100131193,MINK1,RNF152,PPP6R2,SLC26A6 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for DGKD |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Chemistry | ChEMBL | CHEMBL1075120; -. |
Organism-specific databases | PharmGKB | PA27312; -. |
Organism-specific databases | CTD | 8527; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00144 | diacylglycerol kinase, delta 130kDa | approved; nutraceutical | Phosphatidylserine |
Top |
Cross referenced IDs for DGKD |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |